Pages with the most revisions

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

1. EPOCH-DA‏‎ (16 revisions)
2. Main Page‏‎ (11 revisions)
3. Adrenocortical Carcinoma‏‎ (11 revisions)
4. Acute Myeloid Leukemia,Adult‏‎ (10 revisions)
5. Stem Cell Transplantation‏‎ (8 revisions)
6. Lymphoma Non-Hodgkin's, Adult‏‎ (6 revisions)
7. Multiple Myeloma And Plasma Cell Dyscrasias‏‎ (6 revisions)
8. Lymphoma Hodgkin's, Adult‏‎ (4 revisions)
9. CLAG-M‏‎ (4 revisions)
10. BEAM‏‎ (4 revisions)
11. Cyclophosphamide Bortezomib Dexamethasone‏‎ (4 revisions)
12. Cytotoxic Regimens‏‎ (4 revisions)
13. Clofarabine, cyclophosphamide and etoposide‏‎ (3 revisions)
14. Pancreatic Cancer‏‎ (3 revisions)
15. FOLFIRINOX‏‎ (3 revisions)
16. ATRA plus As203‏‎ (3 revisions)
17. APL4 - ALLG‏‎ (3 revisions)
18. Cancer treatment information‏‎ (3 revisions)
19. Guidelines for contributors‏‎ (3 revisions)
20. Brentuximab vedotin‏‎ (3 revisions)
21. IVE‏‎ (2 revisions)
22. Ifosfamide‏‎ (2 revisions)
23. ICE-aml‏‎ (2 revisions)
24. Kaposi's Sarcoma‏‎ (2 revisions)
25. IFL + Bevacizumab‏‎ (2 revisions)
26. Imatinib‏‎ (2 revisions)
27. Gemcitabine + Paclitaxel‏‎ (2 revisions)
28. Ifosfamide + Paclitaxel‏‎ (2 revisions)
29. IL-2‏‎ (2 revisions)
30. IMVP-16‏‎ (2 revisions)
31. Ketoconazole‏‎ (2 revisions)
32. Kidney Renal Cell Cancer‏‎ (2 revisions)
33. MACOP-B‏‎ (2 revisions)
34. MAID‏‎ (2 revisions)
35. MCP‏‎ (2 revisions)
36. MIME‏‎ (2 revisions)
37. MINE/ESHAP‏‎ (2 revisions)
38. MOPP‏‎ (2 revisions)
39. MOPPABV Hybrid‏‎ (2 revisions)
40. MP‏‎ (2 revisions)
41. M-BACOD‏‎ (2 revisions)
42. Luprolide‏‎ (2 revisions)
43. LALA‏‎ (2 revisions)
44. LV5FU-P‏‎ (2 revisions)
45. Linker Regimen‏‎ (2 revisions)
46. LV + 5-FU + Irinotecan + Bevacizumab‏‎ (2 revisions)
47. Lenalidomide‏‎ (2 revisions)
48. Lenalidomide + Rituximab‏‎ (2 revisions)
49. Lung Cancer Non Small Cell‏‎ (2 revisions)
50. Lung Cancer Small Cell‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)